Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000320017-17-000015
Filing Date
2017-03-17
Accepted
2017-03-17 17:09:58
Documents
2
Effectiveness Date
2017-03-17

Document Format Files

Seq Description Document Type Size
1 8-K 03.16.2017 a8-k03162017.htm DEFA14A 23231
2 EXHIBIT 99.1 EARNINGS PR exhibit991earningspr.htm EX-99.1 101354
  Complete submission text file 0000320017-17-000015.txt   125918
Mailing Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920
Business Address 106 ALLEN ROAD FOURTH FLOOR BASKING RIDGE NJ 07920 908-842-0100
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33650 | Film No.: 17698898
SIC: 8090 Services-Misc Health & Allied Services, NEC